Source: Annual Congress 2002 - Bronchial responsiveness, nebulization, devices and airway inflammation
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Groepenhoff, H. M. Meyer, J. E. Dankert-Roelse, A. Boonstra (Amsterdam, The Netherlands). The predictive value of baseline spirometry values and reversibility history of the patient for a significant reversibility response in children. Eur Respir J 2002; 20: Suppl. 38, 3345

Member's Comments

No comment yet.

Related content which might interest you: Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 =80% predicted Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Clinical diagnosis of current asthma: predictive value of respiratory symptoms in the SAPALDIA study Source: Eur Respir J 2001; 17: 214-219 Year: 2001 The predictive values of bronchodilator reversibility indicators in asthmatic patients with non-obstructive patterns of spirometry Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019 A comparison between the diagnostic value of bronchodilator response in spirometry and questionnaire in determining asthma Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 Accuracy of spirometry in predicting restrictive pulmonary impairment using different spirometric reference values in Chilean population Source: Eur Respir J 2006; 28: Suppl. 50, 203s Year: 2006 Peak expiratory flow records for the diagnosis of occupational asthma: the effect of data quantity on diagnostic sensitivity and specificity Source: Eur Respir J 2001; 18: Suppl. 33, 281s Year: 2001 Pre- and post-bronchodilator spirometric values and the degree of reversibility in patients with COPD Source: Eur Respir J 2004; 24: 332 Year: 2004 Comparison of the asthma control test and % predicted FEV1 in relation to correlation with physicians assessment of asthma control and treatment decisions Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011 Predictive value of spirometry trend and FeNO for difficult to treat asthma in children Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management Year: 2010 The interpretation and discriminatory power of bronchodilator measurements: the influence of baseline lung function and disease type Source: Eur Respir J 2003; 22: Suppl. 45, 276s Year: 2003 The clinical value of trend reports in pulmonary function testing Source: International Congress 2015 – CC5 Interpretation of pulmonary function testing Year: 2015 The predictive value of FEV1 for COPD death in construction workers Source: Eur Respir J 2001; 18: Suppl. 33, 275s Year: 2001 Clinical relevance of constant power exercise duration changes in COPD Source: Eur Respir J 2009; 33: 340-345 Year: 2009 Do changes in spirometric indices and FeNO predict asthma outcomes in children? An individual patient data analysis using results from seven FeNO trials Source: International Congress 2018 – Primary ciliary dyskinesia and lung function tests in respiratory morbidities Year: 2018 Predictive value of sputum eosinophilia for the rapid decline of FEV1 after a three-day withdrawal of therapy in asthmatic subjects Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001 Peak cough flow in childhood: reference values and correlation with clinical parameters in Greek children Source: International Congress 2017 – Insight into childhood asthma and paediatric pulmonology Year: 2017 Measuring the bronchial reversibility in asthmatic children - clinical value of different indices Source: International Congress 2017 – Diagnostic tools and comorbidities in paediatric asthma Year: 2017 The different results of the six minutes walking-test in COPD patients with or without significant improvement of inspiratory capacity after bronchodilator test Source: Eur Respir J 2004; 24: Suppl. 48, 122s Year: 2004 Is residual volume reversibility a better marker than FEV1 reversibility in diagnosing reversible airway disease  in asthma? Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017 Assessment of diagnostic accuracy of lung function indices and FeNO for a positive methacholine challenge in suspected asthmatics Source: International Congress 2018 – Asthma management Year: 2018